Kei Kunimasa

20PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsImmunology not elsewhere classifiedGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Mar 29, 2026
Delayed Tumor Shrinkage Beyond Progressive Disease in Small-Cell Lung Cancer Receiving Immunochemotherapy: A Case Report.

Takahisa Kawamura, Kiyohide Komuta, Shun Futamura

|Mar 11, 2026
Constitutive EGFR Activation Induced by PTPRR Downregulation Confers Resistance to KRAS Inhibitors.

Hiroaki Kanemura, Toshiyuki Takehara, Osamu Maenishi

|Nov 11, 2024
Lorlatinib overcomes alectinib-induced hemolytic anemia in an ALK fusion positive non-small-cell lung cancer patient with severe tumor-associated liver failure: A case report.

Kei Kunimasa, Akito Miyazaki, Motohiro Tamiya

|Sep 24, 2024
Real-world assessment of comprehensive genome profiling impact on clinical outcomes: A single-institution study in Japan.

Kei Kunimasa, Naotoshi Sugimoto, Tomoyuki Yamasaki

|Mar 02, 2024
Exceptionally long-lasting response to dabrafenib plus trametinib treatment in a patient with lung adenocarcinoma harboring the BRAF V600E mutation with high expression of PD-L1: A case report.

Takako Inoue, Kei Kunimasa, Motohiro Tamiya

|Feb 09, 2024
Potent CTLs can be induced against tumor cells in an environment of lower levels of systemic MFG-E8.

Yu Mizote, Takako Inoue, Takashi Akazawa

Pageof 4

Frequent Collaborators

2 joint publications

Yosuke Hirotsu

2 joint publications

Shigenori Nagata

2 joint publications

Takako Inoue

1 joint publications

Keiichiro Honma